PHOENIX, Oct. 18, 2017 -- Solera Health (Solera), a preventive care benefits manager, today announced that they have joined forces with the American Diabetes Association (Association) to connect at-risk Americans to a Diabetes Prevention Program (DPP) recognized by the Centers for Disease Control and Prevention (CDC). The initiative seeks to help millions of Americans prevent or delay the onset of type 2 diabetes by providing a streamlined process for adults at risk for type 2 diabetes to enroll in a community or digital DPP.
The National DPP is a partnership of public and private organizations working together to reduce the growing number of Americans with and at risk for prediabetes and type 2 diabetes. There are currently more than 1,500 DPPs, including brick-and-mortar locations such as community non-profits, health systems, retail pharmacies and faith-based organizations, as well as virtual DPPs that deliver content to mobile devices, computers and/or telephones. All programs are working to make it easier for people at risk for type 2 diabetes to participate in affordable and high-quality lifestyle change programs to reduce their risk and improve their overall health.
According to the CDC’s National Diabetes Statistics Report, 2017, more than 84 million American adults are estimated to have prediabetes and are at risk for developing type 2 diabetes. Nearly 90 percent of American adults who have prediabetes are not aware they have it. Through this collaboration between Solera and the Association, millions of Americans who take the Association’s Type 2 Diabetes Risk Test will now have access to Solera Health’s consumer site Solera4Me, where they can begin the process of being matched with a DPP based on their unique needs and preferences. Empowering patients with choice and a variety of DPP options has proven to have a significant impact on sustained program engagement and improved participant outcomes.
“At the Association, we are focused on preventing, curing and improving the lives of all people affected by diabetes,” said Senior Vice President of Research and Consumer Programs, Tamara Darsow, PhD. “By helping us connect people who are at risk for diabetes with the right DPP to help them prevent or delay the onset of type 2 diabetes, Solera is helping us achieve that mission.”
Solera makes health promotion and chronic disease prevention programs accessible by connecting at-risk individuals with a diverse range of lifestyle modification programs as a covered medical benefit. Solera’s national scalable model was designed to consolidate highly fragmented programs and services into one integrated network, allowing healthcare payers and providers to increase consumer access and participation while lowering associated costs.
“Solera is honored to join forces with the American Diabetes Association as both organizations have many synergies that will enhance access to the Diabetes Prevention Program,” said Brenda Schmidt, CEO, Solera Health. “By combining the Association’s influence and reach with our breadth of DPP providers and health plan reimbursement for DPP as a covered medical benefit, we can have a positive impact on delaying or preventing diabetes for a large portion of America’s population.”
About Solera Health
Solera Health is a preventive care benefits manager that connects patients, payers, and physicians with community organizations and digital therapeutics providers, simply and securely. Solera helps consolidate highly fragmented programs and services into one integrated network, allowing health plans and medical providers to increase consumer participation while lowering associated costs. Solera proactively identifies the “best fit” program provider based on each individual’s unique needs and preferences, which has proven to have a significant impact on improved patient outcomes at a fraction of the cost of traditional medical care. For more information, visit Solera Health at www.soleranetwork.com, call 800-858-1714 or follow us on Twitter @SoleraHealth or LinkedIn.
About the American Diabetes Association
More than 30 million Americans have diabetes, and every 21 seconds another person is diagnosed with diabetes. The American Diabetes Association (Association) is the global authority on diabetes and since 1940 has been committed to its mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. To tackle this global public health crisis, the Association drives discovery in research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and provides support and advocacy for people living with diabetes, those at risk of developing diabetes and the health care professionals who serve them. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).
Media Contacts:
Jessy Green or Kay Kelly
SVM Public Relations
[email protected]
401.490.9700


Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 



